Showing 4 results for Gbs
Gh Khataie , N Shahrokhi ,
Volume 56, Issue 6 (7-1998)
Abstract
Group B streptococcus (GBS) is the most important pathogen identified in bacterial cultures in neonatal sepsis, sepecially with early-onset in developed countries (approximately 1-5/1000 deliveries). Neonatal colonization with group B streptococcus results primarily from vertical transmission during the birth process. GBS carrier rate in pregnant women varies from 4.6 to 41 percent in different geographic populations. Contamination of neonates during passage through the birth canal is high (more than 50%). Of the 191 pregnant women screened in this study, 28 (14.7%) were found to be colonized with GBS, by the culture method. Direct CIE and SCA tests on SBM (Selective Broth Medium) containing mixed flora showed that only 11.5% and 18.3% had positive reaction. A total of 530 patients were studied. GBS was isolated from the blood of 4 infants (5.5%, 4 vs 73 positive cultures). Of 181 cultures of CSF only one case was positive for GBS (8.3%) and had meningitis. In another part of experiment, two false positive reactions were found using serum specimen for detection of GBS antigen by CIE. Sensitivity of CIE and SCA both were 75%, specificity, 99.3% and 98.7%. Conclusion: Although specimen collection and microbiologic methods are important factors in identification of women colonized with GBS, there is significant variation in the proportion of women colonization with GBS. This study suggests that GBS is a much less important cause of neonatal sepsis, but further studies are needed to explore these important issues.
M Qaffarpoor ,
Volume 57, Issue 4 (7-1999)
Abstract
With retrospective evaluation of 44 patients suffering from Guilan-Barre Syndrome (GBS), Chronic Idiopathic Demtyelinative Polyradiculoneuropathy (CIDP) and Myasthenia Gravis (MG) treated with intravenous immunoglobulin, we found following results: 1) Initial symptoms of improvement on forth or fifth days. 2) Maximum recovery for CIDP and MG were after 16-24 and 3-11 days, respectively. 3) No major complication, but mild side effects in 32% of patients. 4) In patients with GBS one grade improvement achieved after 8-30 days. 5) Intravenous immunoglobulin (IVIG) plus plasmapheresis had no advantages over IVIG alone. 6) No reasonable conclusion about relapsing rate and duration of response due to follow up restrictions.
Khosravi N, Noorbakhsh S, Tabatabaei A, Ghavami Y,
Volume 70, Issue 11 (2-2013)
Abstract
Background: Infection with group B streptococcus (GBS) can present with respiratory distress, Pneumonia, meningitis and Osteomyelitis in neonates. The aim of this study was to determine the prevalence of GBS colonization in trachea of intubated neonates.
Methods: This observational analytic study was performed upon 33 intubated neonates due to respiratory distress in neonatal intensive care unit (NICU) Rasoul Hospital in Tehran, Iran during 2010-2012. Tracheal secretions cultured upon TODD-HEWITT BROTH and sheep blood agar 5%., chi-square test was used for compare the qualitative variables. P<0.05 was considered meaningful.
Results: Three cases had positive streptococcal culture (9.1%) and four cases had posi-tive culture for non-streptococcal organisms. no meaningful relation observed between positive GBS culture and neonatal gender, kind of delivery, PROM.
Conclusion: Prevalence of GBS positive results (9%) in present study is very close to GBS colonization in pregnant women although the higher colonization rate of pregnant women are expected.
Reihaneh Pirjani, Ali Akbari Sari, Mahbobeh Shirazi, Amin Nakhostin Ansari, Maryam Rabiei, Amene Abiri,
Volume 80, Issue 3 (6-2022)
Abstract
Background: Streptococcus beta group (GBS: Group B Streptococcus) is a gram-positive coccus that colonizes in the rectovaginal area. About 4.6% to 31.3% of women of childbearing age carry GBS infection. GBS colonization is a risk factor for subsequent infections in pregnant women that can be transmitted to the fetus through vertical transfer and aspiration of infected amniotic fluid. 2% of cases lead to an invasive infection in the baby. In most countries, treatment is done according to the CDC (Centers for Disease Control and Prevention) protocol which is based on culture results. According to studies conducted in our country, treatment is based on risk factors. Therefore, during this study, we decided to compare the results of treatment based on risk factors and treatment based on culture results and other maternal and neonatal complications in these two groups.
Methods: This case-control study was performed on 98 pregnant women aged 35 to 37 weeks who were referred to the perinatal clinic of Arash Hospital from April 2018 to the end of March 2020 and also 200 pregnant women with a GBS risk factor. Samples of rectovaginal discharge of 98 pregnant women were sent to a selected laboratory for culturing. In this group, treatment was performed based on the culture result. The control samples included 200 pregnant mothers who were treated based on risk factors without culture. Then the two groups were compared in terms of pregnancy outcomes.
|
Results: Out of 98 subjects, 24 (24.5%) had positive rectovaginal culture. Individuals treated with antibiotics based on positive culture results did not show a significant difference in terms of observed pregnancy outcomes compared with the control group.
Conclusion: The prevalence of GBS colonization was significantly higher in patients with a history of vaginal discharge than in those without a history. Due to the small number of studies conducted in Iran, it is recommended to conduct studies with a larger sample size in order to explain a more appropriate protocol in terms of effectiveness and economics.
|
